# DEAF1

## Overview
DEAF1 (Deformed Epidermal Autoregulatory Factor 1) is a gene that encodes a transcription factor involved in the regulation of gene expression across various biological processes. The DEAF1 transcription factor is characterized by its complex structure, which includes a SAND domain for DNA binding and a MYND domain for protein interactions, classifying it as a transcriptional regulator. This protein plays a crucial role in cellular differentiation, development, and neural function by modulating the expression of target genes. DEAF1's activity is influenced by its nuclear localization and interactions with other proteins, such as LMO4 and GSK3 kinases, which affect its transcriptional regulation capabilities. Clinically, mutations in the DEAF1 gene are linked to several neurodevelopmental disorders, including autosomal dominant mental retardation 24 (MRD24) and Vulto-van Silfhout-de Vries syndrome (VSVS), highlighting its significance in human health and disease (Zhu2023Vultovan; Nabais2019De).

## Structure
The DEAF1 transcription factor is a protein with a complex molecular structure that includes several distinct domains. It contains a SAND domain, which is crucial for DNA binding and dimerization, characterized by a novel α/β-fold with a positively charged surface patch necessary for its function (Jensik2004Identification; Nabais2019De). Adjacent to the SAND domain is a zinc-binding motif, essential for DNA binding and protein interactions (Jensik2004Identification).

The MYND domain of DEAF1 is a cysteine-rich module organized in a Cys4-Cys2-His-Cys (C4-C2HC) tandem zinc-binding motif, which does not bind DNA but is involved in transcriptional regulation through interactions with corepressor proteins such as SMRT and NCoR (Kateb2012Structural). The MYND domain adopts a cross-brace zinc-binding topology, similar to other MYND domains and RING finger domains (Kateb2012Structural).

DEAF1 also features a nuclear localization signal (NLS) and a nuclear export signal (NES), which regulate its nuclear and cytoplasmic trafficking (Jensik2004Identification). The NES is located near the COOH-terminal MYND domain and has a unique leucine spacing (Jensik2004Identification). DEAF1 can interact with other proteins, such as LMO4, through a specific region that includes an unstructured domain and a coiled coil domain overlapping with the NES (Cubeddu2012Contribution). 

Alternative splicing of DEAF1 results in different isoforms, which can affect its function and localization.

## Function
DEAF1 (Deformed Epidermal Autoregulatory Factor 1) is a transcription factor that plays a significant role in regulating gene expression in healthy human cells. It binds to specific DNA sequences, particularly unmethylated CpG dinucleotide motifs, through its SAND domain, which is crucial for its DNA binding activity (Jensik2014DEAF1). DEAF1 can function as both a transcriptional activator and repressor, depending on the context. It activates the EIF4G3 gene by binding to its promoter, leading to increased promoter activity and mRNA levels (Jensik2014DEAF1). DEAF1 also regulates the serotonin 1A receptor gene, acting as a repressor in serotonergic cells and as an enhancer in nonserotonergic cells, highlighting its cell-specific regulatory roles (Czesak2006CellSpecific).

In the mammary gland, DEAF1 influences epithelial cell proliferation and ductal side-branching, potentially through interactions with the LIM-only protein LMO4 and modulation of target genes like Rac3 (Barker2008Deaf1). DEAF1's activity is modulated by its nuclear localization, facilitated by a nuclear localization signal, and its export from the nucleus is mediated by a nuclear export signal (Jensik2004Identification). These molecular processes underscore DEAF1's involvement in development, neural function, and cellular differentiation.

## Clinical Significance
Mutations in the DEAF1 gene are associated with a range of neurodevelopmental disorders. Pathogenic variants in DEAF1 can lead to two main syndromes: autosomal dominant mental retardation 24 (MRD24) and dyskinesia, seizures, and intellectual developmental disorder syndrome (DYSEIDD), collectively known as DEAF1-associated neurodevelopmental disorders (DAND) (Nabais2019De). MRD24 is caused by de novo variants and is characterized by intellectual disability, speech and motor delays, autism, and sleep disturbances (Nabais2019De). DYSEIDD, a recessively inherited condition, includes symptoms such as microcephaly, dyskinesia, and seizures (Nabais2019De).

Vulto-van Silfhout-de Vries syndrome (VSVS) is another condition linked to de novo heterozygous pathogenic variants in DEAF1. It presents with intellectual disability, global developmental delay, severe expressive language impairment, and behavioral abnormalities (Zhu2023Vultovan). Recessive mutations in DEAF1 have been associated with severe intellectual disability, microcephaly, epilepsy, and movement disorders (Andoni2020A).

Alterations in DEAF1 expression can also impact immune system function and have been linked to psychiatric disorders, including major depression and panic disorder (Faqeih2014Novel). These findings underscore the clinical significance of DEAF1 in various neurological and psychiatric conditions.

## Interactions
DEAF1 (Deformed Epidermal Autoregulatory Factor 1) is a transcription factor that engages in various protein-protein and protein-DNA interactions, playing a significant role in gene regulation. DEAF1 contains a SAND domain, which is crucial for DNA binding, and a MYND domain, which facilitates interactions with corepressor proteins such as SMRT and NCoR. These interactions are essential for DEAF1's transcriptional regulation activity (Kateb2012Structural).

DEAF1 also interacts with the LIM-domain only protein 4 (LMO4), which influences its subcellular localization. The interaction with LMO4 occurs through the N-terminal region of DEAF1 and is crucial for modulating DEAF1's nuclear-cytoplasmic distribution (Cubeddu2012Contribution; Joseph2014The). This interaction is significant in processes such as mammary gland development and breast cancer (Kateb2012Structural).

Additionally, DEAF1 is a substrate for glycogen synthase kinase-3 (GSK3) and interacts with GSK3A and GSK3B kinases. This interaction affects DEAF1's transcriptional activity, particularly in the regulation of the 5-HT1A serotonin receptor gene promoter, which is linked to mood disorders (PilotStorck2010Interactome).

DEAF1's ability to bind DNA is also influenced by its zinc-binding motif and nuclear localization signal, which are essential for its DNA-binding activity (Jensik2004Identification). These interactions highlight DEAF1's multifaceted role in transcriptional regulation and its involvement in various biological processes.


## References


[1. (Faqeih2014Novel) Eissa A. Faqeih, Mohammed Al‐Owain, Dilek Colak, Rosan Kenana, Yusra Al‐Yafee, Mazhor Al‐Dosary, Abdulaziz Al‐Saman, Fadwa Albalawi, Dalia Al‐Sarar, Dalia Domiaty, Maha Daghestani, and Namik Kaya. Novel homozygous deaf1 variant suspected in causing white matter disease, intellectual disability, and microcephaly. American Journal of Medical Genetics Part A, 164(6):1565–1570, March 2014. URL: http://dx.doi.org/10.1002/ajmg.a.36482, doi:10.1002/ajmg.a.36482. This article has 17 citations.](https://doi.org/10.1002/ajmg.a.36482)

[2. (Czesak2006CellSpecific) Margaret Czesak, Sylvie Lemonde, Erica A. Peterson, Anastasia Rogaeva, and Paul R. Albert. Cell-specific repressor or enhancer activities of deaf-1 at a serotonin 1a receptor gene polymorphism. The Journal of Neuroscience, 26(6):1864–1871, February 2006. URL: http://dx.doi.org/10.1523/JNEUROSCI.2643-05.2006, doi:10.1523/jneurosci.2643-05.2006. This article has 167 citations.](https://doi.org/10.1523/JNEUROSCI.2643-05.2006)

[3. (Andoni2020A) Tala Andoni, Sian Ellard, Jogesh Kapadia, and Emma Wakeling. A novel autosomal recessive deaf1 nonsense variant: expanding the clinical phenotype. Clinical Dysmorphology, 29(2):114–117, April 2020. URL: http://dx.doi.org/10.1097/mcd.0000000000000306, doi:10.1097/mcd.0000000000000306. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/mcd.0000000000000306)

[4. (Nabais2019De) Maria J. Nabais Sá, Philip J. Jensik, Stacey R. McGee, Michael J. Parker, Nayana Lahiri, Evan P. McNeil, Hester Y. Kroes, Randi J. Hagerman, Rachel E. Harrison, Tara Montgomery, Miranda Splitt, Elizabeth E. Palmer, Rani K. Sachdev, Heather C. Mefford, Abbey A. Scott, Julian A. Martinez-Agosto, Rüdiger Lorenz, Naama Orenstein, Jonathan N. Berg, Jeanne Amiel, Delphine Heron, Boris Keren, Jan-Maarten Cobben, Leonie A. Menke, Elysa J. Marco, John M. Graham, Tyler Mark Pierson, Ehsan Ghayoor Karimiani, Reza Maroofian, M. Chiara Manzini, Edmund S. Cauley, Roberto Colombo, Sylvie Odent, Christele Dubourg, Chanika Phornphutkul, Arjan P.M. de Brouwer, Bert B.A. de Vries, and Anneke T. Vulto-vanSilfhout. De novo and biallelic deaf1 variants cause a phenotypic spectrum. Genetics in Medicine, 21(9):2059–2069, September 2019. URL: http://dx.doi.org/10.1038/s41436-019-0473-6, doi:10.1038/s41436-019-0473-6. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41436-019-0473-6)

[5. (Cubeddu2012Contribution) Liza Cubeddu, Soumya Joseph, Derek J. Richard, and Jacqueline M. Matthews. Contribution of deaf1 structural domains to the interaction with the breast cancer oncogene lmo4. PLoS ONE, 7(6):e39218, June 2012. URL: http://dx.doi.org/10.1371/journal.pone.0039218, doi:10.1371/journal.pone.0039218. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0039218)

[6. (Jensik2004Identification) Philip J. Jensik, Jodi I. Huggenvik, and Michael W. Collard. Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (deaf-1). Journal of Biological Chemistry, 279(31):32692–32699, July 2004. URL: http://dx.doi.org/10.1074/JBC.M400946200, doi:10.1074/jbc.m400946200. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M400946200)

[7. (Joseph2014The) Soumya Joseph, Ann H. Kwan, Philippa H. Stokes, Joel P. Mackay, Liza Cubeddu, and Jacqueline M. Matthews. The structure of an lim-only protein 4 (lmo4) and deformed epidermal autoregulatory factor-1 (deaf1) complex reveals a common mode of binding to lmo4. PLoS ONE, 9(10):e109108, October 2014. URL: http://dx.doi.org/10.1371/journal.pone.0109108, doi:10.1371/journal.pone.0109108. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0109108)

[8. (Zhu2023Vultovan) Hui Zhu, Shuyao Zhu, Qiong Jiang, Ying Pang, Yu Huang, Yan Chen, Ting Hou, Wenxin Deng, Xingyu Liu, Lan Zeng, Ai Chen, Jin Wang, and Zemin Luo. Vulto-van silfhout-de vries syndrome caused by de novo variants of deaf1 gene: a case report and literature review. Frontiers in Neurology, November 2023. URL: http://dx.doi.org/10.3389/fneur.2023.1251467, doi:10.3389/fneur.2023.1251467. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2023.1251467)

[9. (Jensik2014DEAF1) Philip J. Jensik, Jesse D. Vargas, Sara N. Reardon, Shivakumar Rajamanickam, Jodi I. Huggenvik, and Michael W. Collard. Deaf1 binds unmethylated and variably spaced cpg dinucleotide motifs. PLoS ONE, 9(12):e115908, December 2014. URL: http://dx.doi.org/10.1371/journal.pone.0115908, doi:10.1371/journal.pone.0115908. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0115908)

[10. (PilotStorck2010Interactome) Fanny Pilot-Storck, Emilie Chopin, Jean-François Rual, Anais Baudot, Pavel Dobrokhotov, Marc Robinson-Rechavi, Christine Brun, Michael E. Cusick, David E. Hill, Laurent Schaeffer, Marc Vidal, and Evelyne Goillot. Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor. Molecular &amp; Cellular Proteomics, 9(7):1578–1593, July 2010. URL: http://dx.doi.org/10.1074/mcp.m900568-mcp200, doi:10.1074/mcp.m900568-mcp200. This article has 49 citations.](https://doi.org/10.1074/mcp.m900568-mcp200)

[11. (Kateb2012Structural) F. Kateb, H. Perrin, K. Tripsianes, P. Zou, R. Spadaccini, M. Bottomley, A. Bepperling, S. Ansieau, and M. Sattler. Structural and functional analysis of the deaf-1 and bs69 mynd domains. November 2012. URL: http://dx.doi.org/10.2210/pdb4a24/pdb, doi:10.2210/pdb4a24/pdb. This article has 0 citations.](https://doi.org/10.2210/pdb4a24/pdb)

[12. (Barker2008Deaf1) Holly E Barker, Gordon K Smyth, James Wettenhall, Teresa A Ward, Mary L Bath, Geoffrey J Lindeman, and Jane E Visvader. Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland. BMC Developmental Biology, October 2008. URL: http://dx.doi.org/10.1186/1471-213X-8-94, doi:10.1186/1471-213x-8-94. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-213X-8-94)